Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Yeda discloses peptides for myasthenia gravis

Feb. 18, 1997

Abbott discloses nicotinic cholinergic channel modulators

Feb. 18, 1997

Adenosine kinase inhibitors prepared by Gensia

Feb. 18, 1997

Ampalex trial in AD begins

Feb. 17, 1997

GDNF gene therapy for Parkinson's disease

Feb. 17, 1997

Third launch for Zyprexa

Feb. 17, 1997

Nymox drug candidate for AD to enter phase I

Feb. 14, 1997

HMR synthesizes potent AChE inhibitor

Feb. 14, 1997

Paroxetine inhibits NOS

Feb. 13, 1997

Valproate efficacy in major depressive disorder

Feb. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...